Atlas Brown’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.55M | Sell |
30,004
-83
| -0.3% | -$17.9K | 2.03% | 7 |
|
|
2026
Q1 | $6.54M | Sell |
30,087
-280
| -0.9% | -$62.1K | 1.97% | 8 |
|
|
2025
Q4 | $6.94M | Sell |
30,367
-92
| -0.3% | -$21K | 2.06% | 6 |
|
|
2025
Q3 | $7.05M | Sell |
30,459
-35
| -0.1% | -$7.13K | 2.08% | 6 |
|
|
2025
Q2 | $5.66M | Buy |
30,494
+66
| +0.2% | +$12.3K | 1.82% | 7 |
|
|
2025
Q1 | $6.38M | Sell |
30,428
-106
| -0.3% | -$20.6K | 2.24% | 5 |
|
|
2024
Q4 | $5.43M | Buy |
30,534
+11
| +0% | +$2.02K | 1.86% | 7 |
|
|
2024
Q3 | $6.03M | Sell |
30,523
-99
| -0.3% | -$18.5K | 2.09% | 5 |
|
|
2024
Q2 | $5.25M | Sell |
30,622
-485
| -2% | -$80.3K | 1.88% | 6 |
|
|
2024
Q1 | $5.66M | Buy |
31,107
+1,086
| +4% | +$187K | 2.06% | 5 |
|
|
2023
Q4 | $4.65M | Buy |
30,021
+2
| +0% | +$292 | 1.93% | 7 |
|
|
2023
Q3 | $4.47M | Sell |
30,019
-66
| -0.2% | -$9.69K | 2.04% | 9 |
|
|
2023
Q2 | $4.05M | Buy |
30,085
+15
| +0% | +$2.2K | 1.78% | 10 |
|
|
2023
Q1 | $4.79M | Buy |
30,070
+131
| +0.4% | +$20K | 2.21% | 7 |
|
|
2022
Q4 | $4.84M | Sell |
29,939
-2,534
| -8% | -$389K | 2.38% | 6 |
|
|
2022
Q3 | $4.36M | Sell |
32,473
-752
| -2% | -$108K | 2.22% | 7 |
|
|
2022
Q2 | $5.09M | Buy |
33,225
+67
| +0.2% | +$10.2K | 2.41% | 6 |
|
|
2022
Q1 | $5.38M | Sell |
33,158
-309
| -0.9% | -$44.9K | 2.19% | 6 |
|
|
2021
Q4 | $4.53M | Buy |
33,467
+502
| +2% | +$59.3K | 1.76% | 8 |
|
|
2021
Q3 | $3.56M | Buy |
32,965
+1,132
| +4% | +$129K | 1.55% | 13 |
|
|
2021
Q2 | $3.59M | Buy |
31,833
+1,760
| +6% | +$198K | 1.55% | 14 |
|
|
2021
Q1 | $3.25M | Buy |
30,073
+507
| +2% | +$54.2K | 1.54% | 16 |
|
|
2020
Q4 | $3.17M | Buy |
29,566
+532
| +2% | +$51.1K | 1.64% | 14 |
|
|
2020
Q3 | $2.54M | Buy |
29,034
+76
| +0.3% | +$7.16K | 1.5% | 15 |
|
|
2020
Q2 | $2.84M | Buy |
28,958
+1,211
| +4% | +$107K | 1.8% | 11 |
|
|
2020
Q1 | $2.11M | Buy |
27,747
+654
| +2% | +$55.7K | 1.65% | 13 |
|
|
2019
Q4 | $2.4M | Buy |
27,093
+2,195
| +9% | +$182K | 1.5% | 18 |
|
|
2019
Q3 | $1.89M | Sell |
24,898
-1,474
| -6% | -$101K | 1.35% | 20 |
|
|
2019
Q2 | $1.92M | Buy |
26,372
+468
| +2% | +$36.8K | 1.33% | 20 |
|
|
2019
Q1 | $2.09M | Sell |
25,904
-1,593
| -6% | -$130K | 1.48% | 17 |
|
|
2018
Q4 | $2.54M | Sell |
27,497
-2,694
| -9% | -$237K | 1.96% | 10 |
|
|
2018
Q3 | $2.85M | Sell |
30,191
-1,009
| -3% | -$95.7K | 1.75% | 10 |
|
|
2018
Q2 | $302K | Buy |
31,200
+608
| +2% | +$59.4K | 0.07% | 119 |
|
|
2018
Q1 | $2.9M | Buy |
30,592
+805
| +3% | +$88.4K | 0.53% | 11 |
|
|
2017
Q4 | $3.14M | Sell |
29,787
-1,368
| -4% | -$129K | 0.56% | 10 |
|
|
2017
Q3 | $2.77M | Buy |
31,155
+6,046
| +24% | +$460K | 0.59% | 11 |
|
|
2017
Q2 | $1.82M | Sell |
25,109
-120
| -0.5% | -$8.07K | 1.59% | 12 |
|
|
2017
Q1 | $1.64M | Buy |
25,229
+759
| +3% | +$47.7K | 1.3% | 20 |
|
|
2016
Q4 | $1.54M | Hold |
24,470
| – | – | 0.64% | 20 |
|
|
2016
Q3 | $1.54M | Buy |
24,470
+48
| +0.2% | +$3.11K | 0.64% | 20 |
|
|
2016
Q2 | $1.51M | Buy |
24,422
+1,251
| +5% | +$76.2K | 0.61% | 20 |
|
|
2016
Q1 | $1.32M | Buy |
23,171
+428
| +2% | +$23.9K | 0.55% | 22 |
|
|
2015
Q4 | $1.3M | Buy |
22,743
+100
| +0.4% | +$5.76K | 0.83% | 18 |
|
|
2015
Q3 | $1.23M | Buy |
22,643
+201
| +0.9% | +$13.1K | 0.53% | 26 |
|
|
2015
Q2 | $1.55M | Buy |
22,442
+2,413
| +12% | +$158K | 0.6% | 22 |
|
|
2015
Q1 | $1.17M | Buy |
20,029
+1,275
| +7% | +$77K | 0.32% | 31 |
|
|
2014
Q4 | $1.23M | Buy |
18,754
+208
| +1% | +$13.1K | 0.33% | 33 |
|
|
2014
Q3 | $1.07M | Sell |
18,546
-1,235
| -6% | -$68.6K | 0.4% | 35 |
|
|
2014
Q2 | $1.12M | Buy |
19,781
+1,240
| +7% | +$65.1K | 0.55% | 28 |
|
|
2014
Q1 | $953K | Sell |
18,541
-573
| -3% | -$29K | 0.51% | 28 |
|
|
2013
Q4 | $1.01M | Buy |
19,114
+1,143
| +6% | +$56.2K | 0.71% | 20 |
|
|
2013
Q3 | $804K | Sell |
17,971
-9,992
| -36% | -$443K | 0.6% | 24 |
|
|
2013
Q2 | $1.16M | Buy |
+27,963
| New | +$1.22M | 0.25% | 49 |
|
Other funds holding ABBV
HCM
AAMU
CRM
CNB
P
EB